By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its third-quarter revenues increased 16 percent year over year, with strong growth for its diagnostics services business.

The San Diego-based maker of molecular diagnostics and genetic analysis products had total revenues of $13.6 million for the three months ended Sept. 30, compared to $11.7 million for the third quarter of 2010. It fell short of analysts' consensus estimate of $13.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.